Global Information
회사소개 | 문의

세계의 바이오칩 시장 예측

Global Biochips Market Forecast 2019-2027

리서치사 Inkwood Research
발행일 2019년 03월 상품 코드 603658
페이지 정보 영문 127 Pages
가격
US $ 2,500 ₩ 2,858,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,430,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. PDF 파일은 Copy & Paste가 되지 않습니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,145,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 바이오칩 시장 예측 Global Biochips Market Forecast 2019-2027
발행일 : 2019년 03월 페이지 정보 : 영문 127 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 바이오칩 시장 전망에 대해 분석했으며, 제품 특성 및 시장의 구조, 주요 시장 촉진·억제요인, 전체적인 시장 규모 동향 전망(향후 9년간), 종류별·기판 재료별·최종사용자별 및 지역별 상세 동향, 관련 산업과의 연관 구조와 시장 기회, 시장 경쟁 환경, 주요 기업 개요 등을 조사하여 전해드립니다

제1장 분석 범위

제2장 분석 방법

제3장 개요

제4장 시장 역학

  • 모시장(PARENT MARKET) 분석 : 게노믹스/프로테오믹스 시장
  • '바이오칩' 시장의 어원
  • 시장의 정의와 범위
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 과제

제5장 종류별 시장

  • DNA 칩
    • 농업·바이오테크놀러지
    • 암 진단·치료
    • Drug Discovery
    • 유전자 발현
    • 게노믹스
    • SNP(단일염기다형성) 제노타이핑
    • 기타
  • 랩온어칩(Lab-on-a-Chip)
    • 임상 진단
    • Drug Discovery
    • 게노믹스
    • POC(Point of Care) 진단/IVS(체외진단)
    • 프로테오믹스
    • 기타
  • 단백질 칩
    • 진단
    • Drug Discovery
    • 발현 프로파일링
    • 하이 스루풋 스크리닝(HIGH THROUGHPUT SCREENING)
    • 프로테오믹스
    • 기타
  • 기타 칩
    • 세포 어레이
    • 조직 어레이

제6장 기판 재료별 시장

  • 유리
  • 폴리머
  • 실리콘
  • 기타 기판 재료

제7장 최종사용자별 시장

  • 바이오테크놀러지 기업/제약기업
  • 병원/진단 센터
  • 교육·연구기관

제8장 주요 분석 지표

  • Porter의 산업 분석
  • 시장 기회 매트릭스
  • 벤더 환경
  • 밸류체인 분석
    • 연구개발(R&D)
    • 원재료
    • 제조
    • 도매업체/소매업체/유통업체
    • 최종사용자
  • 법령·정책·규제 프레임워크
  • 주요 구입 기준
    • 비용
    • 용도
    • 제품 종류
  • 투자 분석
    • 지역별 투자 기회
    • 최종사용자 분류별 투자 기회
    • 바이오칩 종류별 투자 기회

제9장 지역별 분석

  • 북미(미국, 캐나다)
  • 유럽(독일, 영국, 프랑스, 이탈리아, 스페인 등)
  • 아시아태평양(중국, 일본, 인도, 한국, 호주 등)
  • 기타 국가(RoW : 라틴아메리카, 중동·아프리카)

제10장 경쟁 환경

  • 시장 점유율 분석
  • 주요 기업 분석(총 4사)
  • 기업 전략
    • 사업 제휴·협업
    • 기업인수합병(M&A)
  • 기업 개요
KSA 18.03.05

LIST OF TABLES

  • TABLE 1: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)
  • TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN UNITED STATES IN 2017
  • TABLE 3: NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017
  • TABLE 4: ESTIMATED R&D EXPENDITURE IN MEDICAL & HEALTHCARE INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)
  • TABLE 5: ESTIMATED R&D SPENDING IN BIOTECHNOLOGY, PHARMACEUTICAL, & MEDICAL INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)
  • TABLE 6: GLOBAL BIOCHIPS MARKET, BY TYPE, 2019-2027, (IN $ MILLION)
  • TABLE 7: GLOBAL DNA CHIPS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 8: GLOBAL DNA CHIPS MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 9: GLOBAL LAB ON A CHIP MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 10: GLOBAL LAB ON A CHIP MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 11: GLOBAL PROTEIN CHIPS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 12: GLOBAL PROTEIN CHIPS MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 13: GLOBAL OTHER CHIPS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 14: GLOBAL OTHER CHIPS MARKET, BY APPLICATIONS, 2019-2027 (IN $ MILLION)
  • TABLE 15: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS
  • TABLE 16: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
  • TABLE 17: GLOBAL GLASS MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 18: GLOBAL POLYMERS MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 19: GLOBAL SILICON MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 20: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 21: GLOBAL BIOCHIPS MARKET, BY END-USERS, 2019-2027 (IN $ MILLIONS)
  • TABLE 22: GLOBAL BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 23: GLOBAL HOSPITALS & DIAGNOSTICS CENTERS MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 24: GLOBAL ACADEMIC & RESEARCH INSTITUTE MARKET, BY REGION, 2019-2027 (IN $ MILLIONS)
  • TABLE 25: OPPORTUNITY MATRIX
  • TABLE 26: VENDOR LANDSCAPE
  • TABLE 27: LEGAL, POLICY & REGULATORY FRAMEWORK
  • TABLE 28: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, 2019-2027, (IN $ MILLION)
  • TABLE 29: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 30: EUROPE BIOCHIPS MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 31: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • TABLE 32: REST OF WORLD BIOCHIPS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 33: LIST OF PARTNERSHIP & COLLABORATION
  • TABLE 34: LIST OF MERGERS & ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1: GLOBAL BIOCHIPS MARKET, BY END-USER, 2018 & 2027 (IN %)
  • FIGURE 2: NORTH AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 3: ASIA PACIFIC BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 4: EVOLUTION & TRANSITION OF BIOCHIPS
  • FIGURE 5: WORLDWIDE HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP)
  • FIGURE 6: UNITED STATES HEALTHCARE SPENDING, 2015-2025 (% OF GDP)
  • FIGURE 7: COMPARISON OF HEALTHCARE SPENDING PER CAPITA & OUT OF THE POCKET HEALTH EXPENDITURE
  • FIGURE 8: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 9: GLOBAL DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)
  • FIGURE 10: GLOBAL DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)
  • FIGURE 11: GLOBAL DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
  • FIGURE 12: GLOBAL DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)
  • FIGURE 13: GLOBAL DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 14: GLOBAL DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION)
  • FIGURE 15: GLOBAL DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 16: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)
  • FIGURE 17: GLOBAL LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)
  • FIGURE 18: GLOBAL LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
  • FIGURE 19: GLOBAL LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 20: GLOBAL LAB ON A CHIP MARKET, BY POINT OF CARE (POC) & IN-VITRO DIAGNOSIS (IVS), 2019-2027 (IN $ MILLION)
  • FIGURE 21: GLOBAL LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 22: GLOBAL LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)
  • FIGURE 23: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 24: GLOBAL PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)
  • FIGURE 25: GLOBAL PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
  • FIGURE 26: GLOBAL PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)
  • FIGURE 27: GLOBAL PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)
  • FIGURE 28: GLOBAL PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
  • FIGURE 29: GLOBAL PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 30: GLOBAL BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
  • FIGURE 31: GLOBAL OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)
  • FIGURE 32: GLOBAL OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)
  • FIGURE 33: GLOBAL BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)
  • FIGURE 34: GLOBAL BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)
  • FIGURE 35: GLOBAL BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)
  • FIGURE 36: GLOBAL BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
  • FIGURE 37: GLOBAL BIOCHIPS MARKET, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)
  • FIGURE 38: GLOBAL BIOCHIPS MARKET, BY HOSPITALS & DIAGNOSTICS CENTRES, 2019-2027 (IN $ MILLIONS)
  • FIGURE 39: GLOBAL BIOCHIPS MARKET, BY ACADEMIC & RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)
  • FIGURE 40: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 41: VALUE CHAIN ANALYSIS
  • FIGURE 42: KEY IMPACT ANALYSIS
  • FIGURE 43: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET IN 2018, BY REGION
  • FIGURE 44: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET IN 2018, BY END-USER
  • FIGURE 45: INVESTMENT OPPORTUNITIES IN BIOCHIPS MARKET IN 2018, BY TYPE
  • FIGURE 46: GLOBAL BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
  • FIGURE 47: UNITED STATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 48: CANADA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 49: UNITED KINGDOM BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 50: FRANCE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 51: GERMANY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 52: ITALY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 53: SPAIN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 54: REST OF EUROPE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 55: CHINA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 56: JAPAN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 57: INDIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 58: SOUTH KOREA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 59: AUSTRALIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 60: REST OF ASIA PACIFIC BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 61: LATIN AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 62: MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
  • FIGURE 63: MARKET SHARE ANALYSIS OF KEY PLAYERS IN 2018 (IN %)

KEY FINDINGS

The global biochips market is expected to grow considerably over the forecast years of 2019-2027. Factors like growing investments for R&D, government funding and increasing demand for personalized medicines is expected to lead to a 20.63% CAGR for this market by the end of 2027. Extensive diagnostic application and the major integration of biochips for analytical studies of effectors triggering changes in the environment are influential for the uptake of biochips in the current market.

MARKET INSIGHTS

The global biochip market is very dynamic with respect to the presence of many international players. Most of these companies are engaged for the determination of new varieties of biochip research and development. They are trying to compete with each other by providing the same characteristics at similar prices or by similar features at competitive prices. The progress in the technology and innovations of the biochips, biotechnology, and biosensors have resulted in several new applications of biomedical devices, thereby, providing several opportunities for the biochips market to expand.

Segmentation of the global biochip market is done according to the substrates, types, and end users.

REGIONAL INSIGHTS

The geographical segmentation of the global biochips market is carried out over North America, Asia-Pacific, Europe and the Rest of World. The Asia Pacific biochips market is expected to rise with the highest CAGR over the forecast period of 2019-2027, driven by the emerging economies of countries like Japan, India, and China. The increasing investment in the biochips R&D, supportive incentives from the governments and the solidifying presence of CROs in the region are propagating the market expansion.

Conversely, North America leads the market by capturing the largest market share of xx% in the year 2018. Large-scale research projects in biosciences coupled with the advancements in the pharmaceutical & biotechnology sector of North America are presenting lucrative opportunities to the regional market for further developments.

COMPETITIVE INSIGHTS

Collaboration, partnerships, acquisition, & product launch are some of the key strategies followed by several enterprises within the global biochips market. Eminent companies like the IMGENEX, Thermo Fisher Scientific Inc., Illumina Inc., Samsung Electronics Inc., Cepheid Inc., Fluidigm Corporation, Biochain Institute Inc., Agilent Technology Inc., Gamida for Life Group, Bio-Rad Laboratories Inc., Merck GmbH, OriGene Technologies Inc., Cybrdi Inc., PerkinElmer Inc. and bioMerieux SA are competitively operating in the global biochips market.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY & FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. NORTH AMERICA DOMINATES THE OVERALL MARKET
    • 3.2.2. ASIA PACIFIC IS THE FASTEST EVOLVING REGIONAL MARKET
    • 3.2.3. DNA CHIPS ACCOUNTS FOR THE LARGEST REVENUE SHARE OF TYPE SEGMENT
    • 3.2.4. HOSPITALS & DIAGNOSTICS CENTRES - KEY END-USER VERTICAL
    • 3.2.5. PROTEIN CHIP TYPE IS PROJECTED TO RISE AT HIGHEST GROWTH RATE

4. MARKET DYNAMICS

  • 4.1. PARENT MARKET ANALYSIS: GENOMICS & PROTEOMICS MARKET
  • 4.2. ETYMOLOGY OF BIOCHIPS MARKET
  • 4.3. MARKET DEFINITION & SCOPE
  • 4.4. MARKET DRIVERS
    • 4.4.1. RISING INCIDENCES OF CANCER
    • 4.4.2. INCREASED GOVERNMENT FUNDING, R&D INVESTMENT IN BIOTECHNOLOGY
    • 4.4.3. GROWING INTEREST IN PERSONALIZED MEDICINES
    • 4.4.4. SIGNIFICANT GROWTH IN THE HEALTHCARE EXPENDITURE ACROSS GEOGRAPHIES
  • 4.5. MARKET RESTRAINTS
    • 4.5.1. LACK OF HEALTHCARE COVERAGE
    • 4.5.2. AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
    • 4.5.3. LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
  • 4.6. MARKET OPPORTUNITIES
    • 4.6.1. TECHNOLOGICAL ADVANCEMENT IN THE BIOTECHNOLOGY
    • 4.6.2. IMMENSE GROWTH OPPORTUNITIES IN SUB-CONTINENT OF ASIA
    • 4.6.3. GROWING APPLICATIONS OF BIOCHIPS
  • 4.7. MARKET CHALLENGES
    • 4.7.1. COMPLEXITY OF BIOLOGICAL SYSTEMS
    • 4.7.2. LACK OF COMMON REGULATORY STANDARDS
    • 4.7.3. HIGH INSTRUMENTATION COST

5. MARKET BY TYPE

  • 5.1. DNA CHIPS
    • 5.1.1. AGRICULTURAL BIOTECHNOLOGY
    • 5.1.2. CANCER DIAGNOSTICS & TREATMENT
    • 5.1.3. DRUG DISCOVERY
    • 5.1.4. GENE EXPRESSION
    • 5.1.5. GENOMICS
    • 5.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
    • 5.1.7. OTHER DNA CHIPS APPLICATIONS
  • 5.2. LAB ON A CHIP
    • 5.2.1. CLINICAL DIAGNOSTICS
    • 5.2.2. DRUG DISCOVERY
    • 5.2.3. GENOMICS
    • 5.2.4. POINT OF CARE (POC) & IN-VITRO DIAGNOSIS (IVS)
    • 5.2.5. PROTEOMICS
    • 5.2.6. OTHER LAB ON A CHIP APPLICATIONS
  • 5.3. PROTEIN CHIPS
    • 5.3.1. DIAGNOSTICS
    • 5.3.2. DRUG DISCOVERY
    • 5.3.3. EXPRESSION PROFILING
    • 5.3.4. HIGH THROUGHPUT SCREENING
    • 5.3.5. PROTEOMICS
    • 5.3.6. OTHER PROTEIN CHIP APPLICATIONS
  • 5.4. OTHER CHIPS
    • 5.4.1. CELL ARRAYS
    • 5.4.2. TISSUE ARRAYS

6. MARKET BY SUBSTRATE MATERIALS

  • 6.1. GLASS
  • 6.2. POLYMERS
  • 6.3. SILICON
  • 6.4. OTHER SUBSTRATE MATERIALS

7. MARKET BY END-USERS

  • 7.1. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
  • 7.2. HOSPITALS & DIAGNOSTICS CENTRES
  • 7.3. ACADEMIC & RESEARCH INSTITUTE

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCE MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE
    • 8.1.3. BARGAINING POWER OF SUPPLIERS
    • 8.1.4. BARGAINING POWER OF BUYERS
    • 8.1.5. THREAT OF COMPETITIVE RIVALRY
  • 8.2. OPPORTUNITY MATRIX
  • 8.3. VENDOR LANDSCAPE
  • 8.4. VALUE CHAIN ANALYSIS
    • 8.4.1. RESEARCH & DEVELOPMENT
    • 8.4.2. RAW MATERIALS
    • 8.4.3. MANUFACTURING
    • 8.4.4. WHOLESALERS/RETAILERS/DISTRIBUTORS
    • 8.4.5. END-USERS
  • 8.5. LEGAL, POLICY & REGULATORY FRAMEWORK
  • 8.6. KEY BUYING CRITERIA
    • 8.6.1. COST
    • 8.6.2. APPLICATIONS
    • 8.6.3. PRODUCT TYPE
  • 8.7. INVESTMENT ANALYSIS
    • 8.7.1. BY REGION
    • 8.7.2. BY END-USERS
    • 8.7.3. BY BIOCHIPS TYPE

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. UNITED KINGDOM
    • 9.2.2. FRANCE
    • 9.2.3. GERMANY
    • 9.2.4. ITALY
    • 9.2.5. SPAIN
    • 9.2.6. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. CHINA
    • 9.3.2. JAPAN
    • 9.3.3. INDIA
    • 9.3.4. SOUTH KOREA
    • 9.3.5. AUSTRALIA
    • 9.3.6. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET SHARE ANALYSIS
  • 10.2. KEY COMPANY ANALYSIS
  • 10.3. CORPORATE STRATEGIES
    • 10.3.1. PARTNERSHIP & COLLABORATION
    • 10.3.2. MERGERS & ACQUISITIONS
  • 10.4. COMPANY PROFILES
    • 10.4.1. AGILENT TECHNOLOGY INC.
    • 10.4.2. BIOCHAIN INSTITUTE INC.
    • 10.4.3. BIOMERIEUX SA
    • 10.4.4. BIO-RAD LABORATORIES INC.
    • 10.4.5. CEPHEID INC.
    • 10.4.6. CYBRDI INC.
    • 10.4.7. FLUIDIGM CORPORATION
    • 10.4.8. GAMIDA FOR LIFE GROUP
    • 10.4.9. ILLUMINA INC.
    • 10.4.10. IMGENEX
    • 10.4.11. MERCK GMBH
    • 10.4.12. ORIGENE TECHNOLOGIES INC.
    • 10.4.13. PERKINELMER INC.
    • 10.4.14. SAMSUNG ELECTRONICS INC.
    • 10.4.15. THERMO FISHER SCIENTIFIC INC.
Back to Top
전화 문의
F A Q
 
BCC Research